Corticosteroid use in critically ill patients
Open Access
- 1 January 2023
- journal article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Galenika Medical Journal
- Vol. 2 (7) , 27-33
Abstract
The use of corticosteroids as immunosuppressants in critically ill patients is a very complex issue. These potent immunomodulators can be used in the treatment of critically ill patients with severe community-acquired pneumonia (SCAP) and/or septic shock. Local and systemic inflammatory responses are increased in SCAP, thus impairing gas exchange. Also, persistent inflammatory response is associated with higher mortality in patients with COVID-19 and non-COVID-19-related ARDS. However, the risk of administering systemic steroids (methylprednisolone, Dexamethasone, hydrocortisone, etc.) to non-responders is evident. In general, the use of corticosteroids in critically ill patients should not be routine (one size fits all approach) but as personalized and individualized as clinically possible (from one size does not fit all to one size fits one).Keywords
This publication has 35 references indexed in Scilit:
- Communication between genomic and non-genomic signaling events coordinate steroid hormone actionsSteroids, 2018
- Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patientsPLOS ONE, 2018
- Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017Intensive Care Medicine, 2017
- Assessment of immune organ dysfunction in critical illness: utility of innate immune response markersIntensive Care Medicine Experimental, 2017
- Plasma cytokine levels predict response to corticosteroids in septic shockIntensive Care Medicine, 2016
- CorticosteroidsRheumatic Disease Clinics of North America, 2016
- Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory ResponseJAMA, 2015
- A practical guide to the monitoring and management of the complications of systemic corticosteroid therapyAllergy, Asthma & Clinical Immunology, 2013
- Immunomodulatory agents in the treatment of community-acquired pneumonia: A systematic reviewJournal of Infection, 2011
- The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insightsMolecular and Cellular Endocrinology, 2011